Evidence map›Paper›PMID 38160057›Full record

ArticleTobacco control2025

Tobacco, nicotine and counter-marketing promotions using Instagram's branded content tool.

Linnea Laestadius, Kelsey Van Hoorn, Julia Vassey, Jenny Ozga, Cassandra Stanton, Dongmei Li, Eileen Han, Daniel Romer

Open access · hybridAbstract read
In one paragraph

Article in Tobacco control, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 1 country.

Linnea LaestadiusZilber College of Public Health, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin, USA llaestad@uwm.edu.ORCID 0000-0003-3272-9317
Kelsey Van HoornZilber College of Public Health, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin, USA.
Julia VasseyDepartment of Population and Public Health Sciences, University of Southern California, Los Angeles, California, USA.ORCID 0000-0003-3002-2000
Jenny OzgaBehavioral Health and Health Policy Practice, Westat Inc, Rockville, Maryland, USA.ORCID 0000-0003-2543-561X
Cassandra StantonBehavioral Health and Health Policy Practice, Westat Inc, Rockville, Maryland, USA.ORCID 0000-0001-5329-6261
Dongmei LiDepartment of Clinical and Translational Research, University of Rochester Medical Center, Rochester, New York, USA.ORCID 0000-0001-9140-2483
Eileen HanCenter for Tobacco Control Research and Education, University of California San Francisco, San Francisco, California, USA.
Daniel RomerAnnenberg Public Policy Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
University of Wisconsin–Milwaukee · USWestat (United States) · USUniversity of California, San Francisco · USUniversity of Pennsylvania · USUniversity of Rochester Medical Center · USUniversity of Southern California · US

Funding

USC Tobacco Center of Regulatory ScienceU54CA180905 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Jennifer Beth Unger · 2018 to 2026
$39.0M
Leadership and Logistics CoreU54DA046060 · NIDA · WESTAT, INC. · PI Andrea M Stroup · 2018 to 2026
$28.1M
Vaporized Nicotine Product Initiation Among Youth in the US, Canada, and England: Methods to Predict Uptake and Policy EfficacyP01CA200512 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI FONG, GEOFFREY T · 2016 to 2025
$25.3M
PROJECT 5: IMPACT OF CHANGING TOBACCO PRODUCT USE ON HEALTHCARE COSTS FOR GENERAL AND VULNERABLE POPULATIONSU54HL147127 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LING, PAMELA MAY · 2018 to 2022
$20.4M
WNY Center for Research on Flavored Tobacco Products (CRoFT)U54CA228110 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI OSSIP, DEBORAH J · 2018 to 2022
$19.8M
NCI NIH HHS P01 CA200512NCI NIH HHS U54 CA180905NCI NIH HHS U54 CA228110NHLBI NIH HHS U54 HL147127NIDA NIH HHS U54 DA046060
6 · The paper itself

Abstract

backgroundThe social media conglomerate, Meta, has a policy prohibiting promotion of tobacco products, vaporisers, electronic cigarettes or other products that simulate smoking via their branded content tools. This study examines if branded Instagram posts comply with these self-regulatory efforts.

methodsWe analysed the presence and content of tobacco/nicotine promotion, as well as counter-marketing, in a sample of 400 branded/paid partnership-labelled Instagram posts with tobacco/nicotine-related terms made between 31 July 2022 and 31 March 2023, gathered from Meta's CrowdTangle tool and classified by CrowdTangle as being in English.

resultsOf the 217 active branded posts that mentioned or depicted tobacco/nicotine products, most promoted rather than countered the sale of such products (84.3% vs 15.7%, respectively). Posts originating from US Instagram users accounted for 42.6% of promotional content. After the USA, posts from Indonesia (19.1%), Pakistan (9.8%) and India (8.2%) were most frequent. Most posts were fully in English (74.9%). Posts featured hookah (39.4%), electronic nicotine delivery systems (ENDS) accessories (17.5%), ENDS devices and e-liquids (16.9%) and various types of cigars (15.3%). The majority of US posts promoted venues or events where tobacco/nicotine products were featured (71.8%). Almost half of all promotional posts (47.0%) were sponsored by tobacco industry accounts. Posts that encouraged cessation were primarily (47.1%) sponsored by non-government organisations.

conclusionDespite attempts at self-regulation, paid partnership posts promoting tobacco and nicotine products are present on Instagram, especially posts promoting venues and events that feature tobacco and nicotine use. Self-regulation of this content shows limited success, suggesting a need for federal oversight and additional counter-marketing in social media settings.

Indexed as

MarketingNicotineSocial MediaTobacco ProductsElectronic Nicotine Delivery SystemsHumansNicotineElectronic nicotine delivery devicesMediaNon-cigarette tobacco productsSurveillance and monitoringTobacco industry

Identifiers

PMID38160057
PMCPMC11214637
OpenAlexW4390451227

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.